Literature DB >> 9192812

Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas.

K Yashima1, L A Litzky, L Kaiser, T Rogers, S Lam, I I Wistuba, S Milchgrub, S Srivastava, M A Piatyszek, J W Shay, A F Gazdar.   

Abstract

To investigate the role of telomerase in the multistage pathogenesis of lung cancer, we examined 205 fresh and archival tissue samples obtained from 40 patients, 34 of whom had invasive lung carcinoma, 5 with carcinoma in situ (CIS) without invasion, and 1 without lung carcinoma. We analyzed samples for telomerase enzyme activity using the semiquantitative PCR-based telomeric repeat amplification protocol assay (131 samples) or by a radioactive in situ hybridization method for expression of the RNA component of human telomerase (hTR; 74 samples). A subset of samples was assayed by both methods, and the correlation was excellent (30 of 36; 83%). With the exception of a carcinoid tumor and a necrotic squamous cell carcinoma, all tumor cells were moderate to strongly positive for both hTR and telomerase activity, except for foci of keratinization in squamous cell carcinomas. Telomerase positivity, with weak enzyme activity and/or low hTR expression, was present in basal epithelial cells of large bronchi, both histologically normal (26%) and hyperplastic (71%), and in 23% of peripheral lung samples (in epithelium of small bronchi and bronchioles or lymphoid aggregates). More advanced epithelial changes (metaplasia, dysplasia, and CIS) were associated with telomerase dysregulation. Dysregulation in preneoplasia was manifested in three ways: almost all such lesions expressed hTR, although enzyme activity levels were several-fold lower than in the corresponding invasive tumors; cells throughout these multilayered processes expressed hTR; and intense, focal up-regulation of hTR occurred in CIS foci in the vicinity of invasive cancers. Alveolar cells and areas of atypical adenomatous hyperplasia (possible precursor lesions for peripheral adenocarcinomas) were negative. Our studies demonstrate that dysregulation of telomerase occurs early in the multistage pathogenesis of bronchogenic lung carcinomas and that intense focal localized hTR expression in CIS may indicate imminent invasion.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192812

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

1.  Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma.

Authors:  R D Ramirez; S D'Atri; E Pagani; T Faraggiana; P M Lacal; R S Taylor; J W Shay
Journal:  Neoplasia       Date:  1999-04       Impact factor: 5.715

2.  Telomerase expression in uveal melanoma.

Authors:  B Heine; S E Coupland; S Kneiff; G Demel; N Bornfeld; M Hummel; H Stein
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

3.  Telomerase activity detected in oral lichen planus by RNA in situ hybridisation: not a marker for malignant transformation.

Authors:  C O'Flatharta; M Leader; E Kay; S R Flint; M Toner; W Robertson; M J E M F Mabruk
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

Review 4.  Pulmonary preinvasive neoplasia.

Authors:  K M Kerr
Journal:  J Clin Pathol       Date:  2001-04       Impact factor: 3.411

5.  Both transcriptional and posttranscriptional mechanisms regulate human telomerase template RNA levels.

Authors:  X Yi; V M Tesmer; I Savre-Train; J W Shay; W E Wright
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

6.  Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cancer.

Authors:  K Nakano; E Watney; J K McDougall
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

7.  Telomere length and recurrence risk after curative resection in patients with early-stage non-small-cell lung cancer: a prospective cohort study.

Authors:  Eric S Kim; Yuanqing Ye; Ara A Vaporciyan; Jinliang Xing; Maosheng Huang; Jian Gu; Jack A Roth; Scott M Lippman; Xifeng Wu
Journal:  J Thorac Oncol       Date:  2015-02       Impact factor: 15.609

8.  Detection of telomerase in hepatocellular carcinomas using a PCR ELISA assay: comparison with hTR expression.

Authors:  S Ferlicot; V Paradis; D Dargère; G Monges; P Bedossa
Journal:  J Clin Pathol       Date:  1999-10       Impact factor: 3.411

Review 9.  Lung cancer. 9: Molecular biology of lung cancer: clinical implications.

Authors:  K M Fong; Y Sekido; A F Gazdar; J D Minna
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

Review 10.  The field of tissue injury in the lung and airway.

Authors:  Katrina Steiling; John Ryan; Jerome S Brody; Avrum Spira
Journal:  Cancer Prev Res (Phila)       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.